Titan Pharmaceuticals Falls Through the Floor (TTNP)

Alan Masterson - August 10, 2012

Titan Pharmaceuticals (OTC: TTNP) released second quarter results this morning that showed revenues doubling to $1.4 million from the same period in 2011. The top line consisted of royalties on the...

Sign Up To Get Our Latest Stocks Alerts